BNP Paribas Asset Management
CVS icon

BNP Paribas Asset Management’s CVS Health CVS Stock Holding History

BNP Paribas Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6M Sell
746,266
-253,031
-25% -$19.5M 0.06% 297
2025
Q4 		$79.3M Buy
999,297
+547,837
+121% +$43.2M 0.09% 211
2025
Q3 		$34M Sell
451,460
-22,877
-5% -$1.57M 0.09% 239
2025
Q2 		$32.7M Buy
474,337
+251,627
+113% +$16.5M 0.08% 248
2025
Q1 		$15.1M Sell
222,710
-348,977
-61% -$20.9M 0.04% 387
2024
Q4 		$25.7M Buy
571,687
+354,334
+163% +$19.9M 0.06% 287
2024
Q3 		$13.7M Sell
217,353
-361,764
-62% -$21.1M 0.03% 384
2024
Q2 		$34.2M Buy
579,117
+377,739
+188% +$23.6M 0.09% 228
2024
Q1 		$16.1M Sell
201,378
-14,420
-7% -$1.1M 0.04% 343
2023
Q4 		$17M Sell
215,798
-22,468
-9% -$1.6M 0.05% 323
2023
Q3 		$16.6M Sell
238,266
-144,903
-38% -$10.3M 0.05% 316
2023
Q2 		$26.5M Sell
383,169
-191,172
-33% -$13.6M 0.08% 243
2023
Q1 		$42.7M Sell
574,341
-597,054
-51% -$50.1M 0.15% 155
2022
Q4 		$109M Buy
1,171,395
+390,579
+50% +$37.7M 0.39% 55
2022
Q3 		$74.5M Sell
780,816
-125,226
-14% -$12.4M 0.29% 74
2022
Q2 		$84M Buy
906,042
+378,504
+72% +$36.9M 0.32% 72
2022
Q1 		$53.4M Buy
527,538
+252,209
+92% +$26.5M 0.19% 132
2021
Q4 		$28.4M Buy
275,329
+37,582
+16% +$3.47M 0.09% 254
2021
Q3 		$20.2M Sell
237,747
-3,155
-1% -$264K 0.07% 294
2021
Q2 		$20.1M Sell
240,902
-162,995
-40% -$13.3M 0.07% 311
2021
Q1 		$30.4M Buy
403,897
+51,188
+15% +$3.73M 0.13% 195
2020
Q4 		$24.1M Sell
352,709
-28,460
-7% -$1.85M 0.11% 222
2020
Q3 		$22.3M Sell
381,169
-335,908
-47% -$20.9M 0.13% 199
2020
Q2 		$46.6M Sell
717,077
-99,155
-12% -$6.24M 0.32% 79
2020
Q1 		$48.4M Buy
816,232
+21,167
+3% +$1.41M 0.41% 55
2019
Q4 		$59.1M Buy
795,065
+416,584
+110% +$29.3M 0.4% 50
2019
Q3 		$23.9M Buy
378,481
+11,256
+3% +$667K 0.18% 158
2019
Q2 		$20M Sell
367,225
-130,768
-26% -$7.04M 0.16% 172
2019
Q1 		$26.9M Sell
497,993
-485,171
-49% -$29.9M 0.22% 112
2018
Q4 		$64.1M Buy
983,164
+715,751
+268% +$53.4M 0.59% 23
2018
Q3 		$21.1M Buy
267,413
+11,646
+5% +$833K 0.16% 176
2018
Q2 		$16.5M Buy
255,767
+23,493
+10% +$1.55M 0.14% 207
2018
Q1 		$14.4M Sell
232,274
-311,555
-57% -$22.4M 0.12% 229
2017
Q4 		$39.4M Sell
543,829
-60,633
-10% -$4.41M 0.34% 64
2017
Q3 		$49.2M Buy
604,462
+47,284
+8% +$3.74M 0.42% 47
2017
Q2 		$44.8M Sell
557,178
-8,882
-2% -$701K 0.4% 54
2017
Q1 		$44.4M Buy
566,060
+1,767
+0.3% +$141K 0.41% 54
2016
Q4 		$44.5M Sell
564,293
-794,573
-58% -$64.3M 0.43% 51
2016
Q3 		$121M Sell
1,358,866
-114,476
-8% -$10.8M 1.03% 5
2016
Q2 		$141M Buy
1,473,342
+21,529
+1% +$2.15M 1.19% 4
2016
Q1 		$151M Sell
1,451,813
-32,442
-2% -$3.15M 1.28% 5
2015
Q4 		$145M Buy
1,484,255
+241,433
+19% +$23.6M 1.23% 5
2015
Q3 		$120M Sell
1,242,822
-107,747
-8% -$11.3M 1.05% 4
2015
Q2 		$142M Sell
1,350,569
-127,349
-9% -$13M 1.15% 3
2015
Q1 		$153M Sell
1,477,918
-61,425
-4% -$6.22M 1.16% 3
2014
Q4 		$148M Sell
1,539,343
-394,807
-20% -$34.8M 1.2% 3
2014
Q3 		$154M Sell
1,934,150
-104,369
-5% -$8.23M 1.25% 6
2014
Q2 		$154M Sell
2,038,519
-16,115
-0.8% -$1.22M 1.19% 5
2014
Q1 		$154M Buy
2,054,634
+94,364
+5% +$6.67M 1.17% 6
2013
Q4 		$140M Buy
1,960,270
+485,637
+33% +$31.2M 1.05% 7
2013
Q3 		$83.7M Buy
1,474,633
+83,374
+6% +$4.97M 0.63% 31
2013
Q2 		$79.6M Buy
+1,391,259
New +$80.6M 0.59% 37

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BNP Paribas Asset Management's CVS Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its CVS Health (CVS) stake by 25% in Q1 2026, selling an estimated $19.5M and leaving 746,266 shares worth $53.6M. The position accounts for 0.06% of the portfolio, ranked #297.

BNP Paribas Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $154M in Q3 2014. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • BNP Paribas Asset Management held 746,266 shares of CVS Health worth $53.6M as of Q1 2026.
  • BNP Paribas Asset Management sold 253,031 CVS Health shares in Q1 2026, an estimated $19.5M.
  • CVS Health made up 0.06% of BNP Paribas Asset Management's portfolio in Q1 2026, its #297 holding.
  • BNP Paribas Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Asset Management's CVS Health position peaked at $154M in Q3 2014.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.